Regulatorische Updates
14. Sept. 2026•1 Min. Lesezeit
South Korean Lawmaker Proposes Expanding Narcotics Theft‑Prevention Rules to All Controlled Substances
Lawmaker Seo Young‑seok (Democratic Party) introduced a bill to broaden theft‑and‑leak prevention obligations from medical narcotics to all narcotics, including standard substances and raw‑material drugs.
Regulatorische Updates
9. Sept. 2026•1 Min. Lesezeit
South Korea cracks down on illegal sale of imported medicines in traditional market stalls
A joint inspection by South Korea’s MFDS and local governments uncovered 30 import stalls illegally selling overseas OTC and psychotropic medicines in traditional markets.
Regulatorische Updates
7. Sept. 2026•1 Min. Lesezeit
MFDS reveals illegal distribution of unapproved foreign medicines in Korean import markets
A joint inspection of 10 import shopping centers uncovered unapproved Japanese and US medicines, including pain relievers, cold drugs, gastrointestinal meds, and psychoactive substances, sold without approval.
Regulatorische Updates
7. Sept. 2026•1 Min. Lesezeit
Korean National Audit Flags Weak Telemedicine Narcotics Prescription Oversight
The Legislative Research Service highlighted inadequate monitoring of narcotic prescriptions via telemedicine as a 2026 National Audit issue, urging real‑time oversight.
Regulatorische Updates
4. Sept. 2026•1 Min. Lesezeit
Korea Pharmaceutical Safety Agency Highlights Updated Narcotics Regulations at KMA 2026 Conference
The agency announced expanded verification of medical narcotics to include zolpidem and revised safety standards for narcotic analgesics, promoting the changes at the KMA 2026 conference.
Regulatorische Updates
31. Aug. 2026•1 Min. Lesezeit
Korean Lawmaker Reports Decrease in Medical Narcotics Misuse Cases After Legislative Reform
Legislative changes aimed at improving narcotics prescription management have led to a measurable drop in reported misuse cases among medical professionals in 2026, according to Rep. Jeon Jin-suk.